Preventing the flu: Researchers looking for a new approach

Post author:gtmrick
Post published:June 5, 2015
Post category:Uncategorized

Lifetime: New approach to fighting influenza Advertise on CTVNews.ca

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

You Might Also Like

Vasomune and AnGes Announce First Patient Enrolled in Phase 2a Clinical Study Evaluating AV-001 for the Treatment of Severe COVID-19 Disease

Vasomune Announces Government Financial Support for the Development of COVID-19 Therapeutic

Vasomune’s Lead Investigational Medication is Connected to the Fight Against Coronavirus

About

Vasomune Therapeutics 2020 © All Rights Reserved.